Ayurcann Holdings Corp.
AYURF
$0.01
-$0.01-40.91%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.08% | 19.73% | 9.44% | 25.60% | 26.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.08% | 19.73% | 9.44% | 25.60% | 26.27% |
| Cost of Revenue | 25.61% | 34.65% | 15.29% | 11.93% | 17.33% |
| Gross Profit | -36.16% | -46.88% | -0.33% | 49.16% | 42.79% |
| SG&A Expenses | -6.70% | -8.68% | 6.34% | 15.89% | 41.45% |
| Depreciation & Amortization | -47.88% | -82.70% | -10.08% | -14.77% | 25.80% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.79% | 15.80% | 11.32% | 12.46% | 25.65% |
| Operating Income | -1,709.90% | -5.14% | -67.60% | 114.53% | 29.67% |
| Income Before Tax | -343.80% | 5.64% | -102.90% | 84.68% | -15.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -343.80% | 5.64% | -102.90% | 84.68% | -15.92% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -343.80% | 5.64% | -102.90% | 84.68% | -15.92% |
| EBIT | -1,709.90% | -5.14% | -67.60% | 114.53% | 29.67% |
| EBITDA | -638.76% | -9.78% | -321.25% | 204.85% | 27.41% |
| EPS Basic | -355.56% | 13.39% | -100.00% | 88.57% | 10.00% |
| Normalized Basic EPS | -333.33% | 14.29% | -116.67% | 86.36% | 0.00% |
| EPS Diluted | -355.56% | 13.39% | -100.00% | 88.57% | 10.00% |
| Normalized Diluted EPS | -333.33% | 14.29% | -116.67% | 86.36% | 0.00% |
| Average Basic Shares Outstanding | 0.00% | 9.29% | 1.24% | 20.04% | 21.32% |
| Average Diluted Shares Outstanding | 0.00% | 9.29% | 1.24% | 20.04% | 21.32% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |